<DOC>
	<DOCNO>NCT00003255</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combine carboplatin topotecan treating patient relapse acute myelogenous leukemia .</brief_summary>
	<brief_title>Carboplatin Plus Topotecan Treating Patients With Relapsed Acute Myelogenous Leukemia</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy 5-day continuous infusion carboplatin topotecan patient relapse refractory acute myelogenous leukemia ( AML ) . II . Assess toxic effect treatment patient . OUTLINE : Patients receive continuous intravenous infusion topotecan carboplatin 5 day . Treatment repeat every 3-4 week induction ( two course ) every 6-10 week consolidation . No four course treatment give . Patients follow every 6 month 5 year .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Previously establish diagnosis acute myelogenous leukemia : Failure achieve complete remission initial induction regimen First relapse within 1 year initial complete remission Failure achieve complete remission one two course reinduction therapy first relapse Second relapse two different induction regimen Chemotherapyrelated leukemia unfavorable cytogenetics No active CNS leukemia Not eligible allogeneic bone marrow transplant relate donor PATIENT CHARACTERISTICS : Age : 18 74 Performance status : ECOG 02 Life expectancy : At least 4 week Hematopoietic : Not specify Hepatic : Bilirubin great upper limit normal ( ULN ) ( unless elevation due AML ) Renal : Creatinine great 0.3 mg/dL ULN Cardiovascular : No myocardial infarction within past 3 month No congestive heart failure No poorly control cardiac arrhythmia Other : Not pregnant nursing Fertile patient must use adequate contraception No psychosis No active systemic infection PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Recovered toxic effect previous chemotherapy At least 3 day since hydroxyurea Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No prior concurrent aminoglycosides amphotericin B within past 7 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
</DOC>